"We Want to Unleash More Synergy and Creativity": Interview with Dr. Ulf Korthäuer and Dr. Tewis Bouwmeester about the Novartis Labs of the Future (LOTF)

Author：  

Publisher： Swiss Chemical Society

ISSN： 0009-4293

Source： CHIMIA International Journal for Chemistry, Vol.64, Iss.10, 2010-10, pp. : 758-762

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dr Fisher's casebook: “More or less” is about right

By  

SIGNIFICANCE, Vol. 12, Iss. 4, 2015-08 ,pp. : 44-44

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dr. Fisher

By  

SIGNIFICANCE, Vol. 12, Iss. 2, 2015-04 ,pp. : 43-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dr. Fisher

By  

SIGNIFICANCE, Vol. 12, Iss. 3, 2015-06 ,pp. : 43-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Albert Hofmann's Pioneering Work on Ergot Alkaloids and Its Impact on the Search of Novel Drugs at Sandoz, a Predecessor Company of Novartis: Dedicated to Dr. Albert Hofmann on the occasion of his 100th birthday

By Giger Rudolf K.A.   Engel Günter  

CHIMIA International Journal for Chemistry, Vol. 60, Iss. 1-2, 2006-02 ,pp. : 83-87

Swiss Chemical Society

Access to resources Recommend Favorite

Prof. Dr. Dr. h.c. Frantisek Nozicka

By  

Optimization, Vol. 56, Iss. 4, 2007-08 ,pp. : 417-418

Taylor & Francis Ltd

Access to resources Recommend Favorite